CLEC17A | C-type lectin domain family 17, member A | Predicted membrane proteins
| | | | | Group enriched |
DEFB4A | Defensin, beta 4A | Predicted secreted proteins Transporters
| | | | | Group enriched |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted membrane proteins
| | | | | Group enriched |
AMTN | Amelotin | Predicted secreted proteins
| | | | | Group enriched |
C12orf77 | Chromosome 12 open reading frame 77 | | | | | | Group enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
BLK | B lymphoid tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | | | | Group enriched |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
EPHX3 | Epoxide hydrolase 3 | Predicted secreted proteins
| | | | | Group enriched |
FCRL2 | Fc receptor-like 2 | CD markers Predicted membrane proteins
| | | | | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NLRP4 | NLR family, pyrin domain containing 4 | | | | | | Group enriched |
RNF222 | Ring finger protein 222 | Predicted membrane proteins
| | | | | Group enriched |
S100A7A | S100 calcium binding protein A7A | | | | | | Tissue enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes
| | | | | Group enriched |
ALOX12B | Arachidonate 12-lipoxygenase, 12R type | Disease related genes
| | | | | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
DSG3 | Desmoglein 3 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GJB5 | Gap junction protein, beta 5, 31.1kDa | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
IL21 | Interleukin 21 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL24 | Interleukin 24 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
IL36RN | Interleukin 36 receptor antagonist | Disease related genes
| | | | | Group enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LCE3D | Late cornified envelope 3D | | | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Transcription factors
| | | | | Group enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SPRR1B | Small proline-rich protein 1B | Cancer-related genes
| | | | | Group enriched |
TLR10 | Toll-like receptor 10 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
VSIG10L | V-set and immunoglobulin domain containing 10 like | Predicted membrane proteins
| | | | | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted membrane proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CXCL13 | Chemokine (C-X-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
FAM159A | Family with sequence similarity 159, member A | Predicted membrane proteins
| | | | | Group enriched |
IL36G | Interleukin 36, gamma | | | | | | Tissue enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | | | | Group enriched |
PLA2G2D | Phospholipase A2, group IID | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G3 | Phospholipase A2, group III | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
S100A7 | S100 calcium binding protein A7 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SIT1 | Signaling threshold regulating transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Group enriched |